Ophthalmic Case Studies and Novel Approach

In a recent small-scale randomized controlled trial, the Oculeve Intranasal Lacrimal Neurostimulator (Allergan) was found to increase the production of aqueous tears and the secretion of goblet cells. This handheld device functions by administering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve within the nasal cavities. This innovative approach presents a potential new avenue for managing dry eye disease, which currently relies heavily on artificial tears and anti-inflammatory medications.

    Related Conference of Ophthalmic Case Studies and Novel Approach

    August 28-29, 2024

    5th International Conference on Euro Ophthalmology and Eye Surgery

    Aix-en-Provence, France
    September 12-13, 2024

    5th International Conference on Optometry

    Paris, France
    October 10-11, 2024

    34th World Congress on Ophthalmology and Optometry

    Madrid, Spain
    October 10-11, 2024

    10th Global Ophthalmology Meeting

    Madrid, Spain
    October 17-18, 2024

    24th Global Ophthalmologists Annual Meeting

    London, UK
    March 17-18, 2025

    39th European Ophthalmology Congress

    Berlin, Germany
    April 29-30, 2025

    35th International Congress on Vision Science and Eye

    Barcelona, Spain

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in